Takeda CSO Chris Arendt on Transforming Drug Discovery & the R&D Pipeline
Conference Coverage
•
18m
Takeda is entering one of the most pivotal moments in its 245-year history, with a late-stage pipeline poised to transform patient outcomes across three therapeutic areas. Chief Scientific Officer Chris Arendt goes Inside the ICE House to discuss the science behind drug candidates targeting narcolepsy, polycythemia vera, and psoriasis. He explores how AI and computational technologies are reshaping drug discovery and why building the right data foundation is critical to supercharging Takeda's R&D engine.
Up Next in Conference Coverage
-
Inside the ICE House x Las Vegas: Des...
From Lake Las Vegas, Nevada, Nancy Paton, award-winning filmmaker and founder of Desert Rose Films, goes Inside the ICE House to discuss why authentic storytelling is becoming essential for companies looking to connect with audiences. She explains how long-term trust, consistency, and meaningful ...
-
Money 20/20 EU: Visa's Tim Moncrieff ...
-
Global Game Summit: Bubbler Media's G...
Bubbler Media's Gayle Troberman joins Ashley Mastronardi on NYSE Floor Talk
